| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Camidanlumab manufacturers
- Camidanlumab
-
- $563.00
-
2026-07-27
- CAS:921618-45-3
- Purity: 95.00%
- Supply Ability: 10g
|
| | Camidanlumab Basic information |
| Product Name: | Camidanlumab | | Synonyms: | Camidanlumab;Research Grade Camidanlumab(DHB95803);Research Grade Camidanlumab;Camidanlumab (anti-CD25) | | CAS: | 921618-45-3 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Camidanlumab Structure]() |
| | Camidanlumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Camidanlumab Usage And Synthesis |
| Uses | Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia[1]. | | References | [1] Michael J Flynn, et al. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. Mol Cancer Ther. 2016 Nov;15(11):2709-2721. DOI:10.1158/1535-7163.MCT-16-0233 |
| | Camidanlumab Preparation Products And Raw materials |
|